Status:

WITHDRAWN

Cataract Surgery on Advanced Age Related Macular Degeneration Patients

Lead Sponsor:

University of British Columbia

Conditions:

Cataract

Macular Degeneration Advanced

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The degree at which cataract surgery improves visual function in patients with advanced age-related macular degeneration (Advanced AMD) has been an on-going topic of discussion. Our objective in this ...

Eligibility Criteria

Inclusion

  • Patients above the age of fifty with both Advanced AMD and Cataracts bilaterally from the Okanagan Valley will be selected for this study.
  • Patients who chose to have bilateral cataract surgery, were able to understand the research parameters, and had no other severe eye disease that may distort the studies results.
  • Patients will be selected for the study according to the National Eye Institute definition of Advanced AMD.
  • "Advanced AMD (AREDS category 4) is characterized by one or more of the following (in the absence of other causes) in one eye:
  • Geographic atrophy of the RPE involving the foveal center.
  • Neovascular maculopathy that includes the following:
  • Choroidal neovascularization (CNV) defined as pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane
  • Serous and/or hemorrhagic detachment of the neurosensory retina or RPE
  • Retinal hard exudates (a secondary phenomenon resulting from chronic intravascular leakage)
  • Subretinal and sub-RPE fibrovascular proliferation
  • Disciform scar (subretinal fibrosis)"

Exclusion

  • Severe intraoperative or postoperative complications such as retinal detachments, and capsule ruptures
  • Inability to complete the required testing (auto-refractive and visual acuity)
  • Inability to attend appointments
  • Inability to complete the questionnaire with Co-I assistance
  • Severe eye disease that may distort the studies results such as but not limited to Epithelial Basement Membrane Dystrophy (EBMD) and retinal detachments.

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2019

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04045704

Start Date

October 1 2019

End Date

December 1 2019

Last Update

October 4 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.